May Han

This inventor holds 11 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Aveo Pharmaceuticals, Inc., Xoma Technology Ltd., Xoma Technologies, Ltd.. Active years: 2010-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: May Han. Retrieved from https://idiyas.com/inventor/may-han

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 (Patent Applications = 2)

% Patents Active = 63.6

CIPO Patents = 1

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 9.3

ph-index = 5

Forward Citations = 52(Granted Patents)

Company Filing History:

11 out of 42

Aveo Pharmaceuticals, Inc.

Xoma Technologies, Ltd.

patent

where one patent can have more than one assignee

Years Active: 2010-2015

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9096664 - Nucleic acid encoding hepatocyte growth factor (HGF) binding proteins (2015-08-04),

2. 8829164 - Anti-ron antibodies (2014-09-09),

3. 8603478 - Anti-RON antibodies (2013-12-10),

4. 8580930 - Hepatocyte growth factor (HGF) binding proteins (2013-11-12),

5. 8575318 - Hepatocyte growth factor (HGF) binding proteins (2013-11-05),

6. 8273355 - Hepatocyte growth factor (HGF) binding proteins (2012-09-25),

7. 8268315 - [object Object] (2012-09-18),

8. 7943344 - Hepatocyte growth factor (HGF) binding proteins (2011-05-17),

9. 7935502 - Hepatocyte growth factor (HGF) binding proteins (2011-05-03),

10. 7659378 - Hepatocyte growth factor (HGF) binding antibody (2010-02-09),

11. 7649083 - Hepatocyte growth factor (HGF) binding antibody (2010-01-19),

Title: The Innovative Contributions of May Han

Introduction

May Han is a prominent inventor based in Brookline, MA, known for her significant contributions to the field of biotechnology. With a total of 11 patents to her name, she has made remarkable advancements in the development of therapeutic agents targeting various disorders.

Latest Patents

One of her latest patents includes the invention of nucleic acid encoding hepatocyte growth factor (HGF) binding proteins. This invention provides a family of binding proteins that bind and neutralize the activity of hepatocyte growth factor, particularly human HGF. These binding proteins can be utilized as diagnostic and therapeutic agents, especially in treating certain HGF responsive disorders, including specific tumors. Another notable patent is for anti-RON antibodies, which are monoclonal antibodies that bind and inhibit the activation of human RON (Recepteur d'Origine Nantais). These antibodies have potential applications in treating certain forms of cancer associated with RON activation.

Career Highlights

Throughout her career, May Han has worked with several notable companies, including Aveo Pharmaceuticals, Inc. and Xoma Technology Ltd. Her work in these organizations has contributed to the advancement of cancer therapies and other medical innovations.

Collaborations

May has collaborated with esteemed colleagues such as William M. Winston, Jr. and Lyne Breault, further enhancing her research and development efforts in the biotechnology sector.

Conclusion

May Han's innovative work and numerous patents reflect her dedication to advancing medical science and improving therapeutic options for patients. Her contributions continue to have a lasting impact on the field of biotechnology.

Profile summary based on public USPTO records.